Arguably one of the biggest benefits of buy and hold investing is growing dividends.
A prime example of why this is the case is biotherapeutics giant CSL Limited (ASX: CSL).
Based on the current CSL share price, the company’s shares offer investors a rather paltry 1% dividend yield.
In light of this, few people (if any) would class CSL as a dividend share. Especially when compared to the likes of telco giant Telstra Corporation Ltd (ASX: TLS) and big four bank Commonwealth Bank of Australia (ASX: CBA).
However, there will be a small group of investors that get incredibly excited twice a year when CSL pays its dividend – its early investors.
Why is this?
Long before listing on the Australian share market, CSL was known as Commonwealth Serum Laboratories. It was established in Melbourne in 1916 to service the health needs of a nation isolated by war.
Since then it has provided Australians with access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases. Next year it is quite likely to be supplying the country with a COVID-19 vaccine.
CSL eventually landed on the Australian share market in 1994 for the equivalent of 76 cents per share. This means that if you invested $50,000 into its shares at that point, you would have approximately 65,800 shares.
According to a note out of Ord Minnett, its analysts are expecting the company to pay a ~$3.34 dividend in FY 2021. If this proves accurate, it will mean that those early investors will be receiving a yield on cost (the yield on the price you paid for shares) of 440%.
This equates to an incredible $219,772 in dividends over the next 12 months, which is 4.4 times their original investment. All for just buying and then holding onto those shares over the years.
This is quite staggering and goes some way to demonstrating just how effective buy and hold investing can be.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
More reading
- 3 fantastic ASX shares to buy next week
- After 8 months, ASX 200 shares are finally out of correction territory
- Latest ASX stocks to be hit by a broker downgrade
- ASX 200 hits 8-month high. Here’s why we could go higher from here
- CSL (ASX:CSL) share price higher after starting COVID-19 vaccine manufacturing
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Telstra Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post How to get rich with ASX dividend shares appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3eY78ZL
Leave a Reply